WPI 3171 (Alendronate 35 mg)
Pill imprint WPI 3171 has been identified as Alendronate sodium 35 mg.
Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 3171 (Alendronate 35 mg)
- 35 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium stearate
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|21695-0901||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.